Page last updated: 2024-10-26

dilazep and Hypertension, Renal

dilazep has been researched along with Hypertension, Renal in 2 studies

Dilazep: Coronary vasodilator with some antiarrhythmic activity.
dilazep : A member of the class of diazepanes that is 1,4-diazepane substituted by 3-[(3,4,5-trimethoxybenzoyl)oxy]propyl groups at positions 1 and 4. It is a potent adenosine uptake inhibitor that exhibits antiplatelet, antianginal and vasodilator properties.

Hypertension, Renal: Persistent high BLOOD PRESSURE due to KIDNEY DISEASES, such as those involving the renal parenchyma, the renal vasculature, or tumors that secrete RENIN.

Research Excerpts

ExcerptRelevanceReference
"The objective of the present study was to compare the effects of imidapril hydrochloride, an angiotensin converting enzyme inhibitor, and dilazep hydrochloride, an antiplatelet agent, on urinary protein excretion and renal function in patients with chronic glomerulonephritis."7.73Long-term effect of imidapril hydrochloride compared with dilazep hydrochloride administration on blood pressure and renal function in patients with chronic glomerulonephritis. ( Hayakawa, H; Hirata, Y; Kamijo, A; Kimura, K; Nagata, D; Nishimatsu, H; Oba, S; Satonaka, H; Suzuki, E; Takahashi, M; Takeda, R; Yamamoto, Y, 2005)
"The objective of the present study was to compare the effects of imidapril hydrochloride, an angiotensin converting enzyme inhibitor, and dilazep hydrochloride, an antiplatelet agent, on urinary protein excretion and renal function in patients with chronic glomerulonephritis."3.73Long-term effect of imidapril hydrochloride compared with dilazep hydrochloride administration on blood pressure and renal function in patients with chronic glomerulonephritis. ( Hayakawa, H; Hirata, Y; Kamijo, A; Kimura, K; Nagata, D; Nishimatsu, H; Oba, S; Satonaka, H; Suzuki, E; Takahashi, M; Takeda, R; Yamamoto, Y, 2005)
"Treatment with dilazep was continued for a period of 6 months, at the end of which the UAE was reduced form 130 +/- 52 to 46 +/- 26 microg/min (p < 0."2.70Effect of dilazep dihydrochloride on urinary albumin excretion in patients with autosomal dominant polycystic kidney disease. ( Ebihara, I; Koide, H; Nakamura, T; Shimada, N; Takahashi, Y; Tanaka, A; Ushiyama, C, 2001)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Satonaka, H1
Suzuki, E1
Hayakawa, H1
Nishimatsu, H1
Nagata, D1
Oba, S1
Kamijo, A1
Takeda, R1
Takahashi, M1
Yamamoto, Y1
Kimura, K1
Hirata, Y1
Nakamura, T1
Ushiyama, C1
Takahashi, Y1
Tanaka, A1
Shimada, N1
Ebihara, I1
Koide, H1

Trials

1 trial available for dilazep and Hypertension, Renal

ArticleYear
Effect of dilazep dihydrochloride on urinary albumin excretion in patients with autosomal dominant polycystic kidney disease.
    Nephron, 2001, Volume: 88, Issue:1

    Topics: Albuminuria; Dilazep; Female; Humans; Hypertension, Renal; Male; Middle Aged; Polycystic Kidney, Aut

2001

Other Studies

1 other study available for dilazep and Hypertension, Renal

ArticleYear
Long-term effect of imidapril hydrochloride compared with dilazep hydrochloride administration on blood pressure and renal function in patients with chronic glomerulonephritis.
    International heart journal, 2005, Volume: 46, Issue:4

    Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Chronic Disease; Dilazep; Drug Ther

2005